Emphasis on Treatment Type (Antiviral Medications, Anti-Inflammatory Medications, and Others); Route of Administration (Oral, Topical, and Others); Distribution Channel (Retail Pharmacies, Online Pharmacies, Hospital Pharmacies, and Others); Region (North America, Europe, Asia-Pacific, Rest of the World); and Region/Country
The global herpes zoster treatment market is expected to grow at a significant rate of around 4% during the forecast period. Herpes Zoster is a localized, blistering, and painful rash caused by the reactivation of varicella-zoster virus (VZV). Herpes Zoster is also called shingles. The rising incidences of chickenpox and the surging geriatric population are the major contributing factors to the market growth of the herpes zoster treatment. For instance, according to CDC, about 4 million people got chickenpox each year in the United States.
Abbott Laboratory, Bausch Health, Cipla Inc., Camber Pharmaceuticals, GlaxoSmithKline plc, Merck, Novartis AG, Pfizer Inc., Eli Lilly and Co., and Teva Pharmaceutical Industries Ltd. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst treatment type, Antiviral category to witness higher CAGR during the forecast period”
Based on the treatment type, the market has been categorized into antiviral medications, anti-inflammatory medications, and others. The antiviral category is to witness higher CAGR during the forecast period owing to the rising demand for better treatment against the root cause of the disease. Furthermore, the rising geriatric population and increasing disease prevalence in them is also the major factor affecting the market dynamics of the antiviral drug segment in the shingles treatment market.
“Amongst route of administration, the oral drugs to hold a significant share in the market in 2020”
Based on route of administration, the market has been categorized into oral, topical, and others. Among these, oral to hold a significant share in the market in 2020. This is mainly due to the surging demand for anti-inflammatory drugs and antiviral drugs which are mostly available in the forms of tablets and capsules. Furthermore, the ease in the consumption of oral drugs is also an important factor for segmental growth.
“Amongst distribution channel, online pharmacies segment holds the major share”
Based on distribution channels, the herpes zoster treatment market is divided into retail pharmacies, hospital pharmacies, and online pharmacies. Hospital pharmacies grabbed a significant market share in 2020 and are anticipated to grow at a rapid rate in the upcoming years. This is due to the rising prevalence of chronic diseases, increasing surgeries and the increased rate of hospitalization is one of the major factors that is responsible for the market growth of hospital pharmacies. For instance, as per the CDC, up to 4% of people who get shingles are hospitalized for complications. Adults aged 65 and over and people with weakened or suppressed immune systems are more likely to be hospitalized.
“North America to hold a significant share in the market”
For a better understanding of the market adoption of the herpes zoster treatment industry, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. In 2020, North America held a significant share of the global herpes zoster treatment market. This is mainly attributed to the presence of the major players in the region along with the rising cases of herpes zoster the region is attributed to the growth of the zoster treatment market in the region. For instance, as per the CDC, an estimated one million cases of herpes zoster occur annually in the United States. The incidence of Herpes Zoster is approximately 4 cases per 1,000 U.S. population annually. The incidence among people 60 years and older is about 1 case per 100 U.S. populations annually.
Reasons to buy this report:
Customization Options:
The global herpes zoster treatment market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
1. Market Introduction
2. Research Methodology Or Assumption
3. Market Synopsis
4. Executive Summary
5. Impact Of Covid-19 On The Herpes Zoster Treatment Market
6. Herpes Zoster Treatment Market Revenue (usd Bn), 2020-2028f
7. Market Insights By Treatment Type
8. Market Insights By Application
9. Market Insights By Distribution Channel
10. Market Insights By Region
11. Herpes Zoster Treatment Market Dynamics
12. Herpes Zoster Treatment Market Opportunities
13. Herpes Zoster Treatment Market Trends
14. Demand And Supply-side Analysis
15. Value Chain Analysis
16. Competitive Scenario
17. Company Profiled
18. Disclaimer
Research Methodology for the Herpes Zoster Treatment Market Analysis (2022-2028)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global herpes zoster treatment market were the three major steps undertaken to create and analyze the adoption of herpes zoster treatment major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global herpes zoster treatment market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the herpes zoster treatment market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the herpes zoster treatment market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as treatment type, route of administration, and distribution channel. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the herpes zoster treatment market. Further, we conducted factor analysis using dependent and independent variables such as various treatment type, route of administration, and distribution channels of herpes zoster. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the herpes zoster treatment market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global herpes zoster treatment market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2028 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global herpes zoster treatment market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of treatment type, route of administration, and distribution channel in the global herpes zoster treatment market.
The main objective of the Global Herpes Zoster Treatment Market Study
The current & future market trends of the global herpes zoster treatment market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
